Wealth Enhancement Advisory Services’s Cellebrite CLBT Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio CLBT Stock Details CLBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.49M	Buy	407,132 +15,957	+4%	+$211K	0.01%	863
2026 Q1	$5.48M	Buy	391,175 +2,396	+0.6%	+$36.1K	0.01%	865
2025 Q4	$7.15M	Buy	388,779 +29,015	+8%	+$521K	0.01%	845
2025 Q3	$6.65M	Buy	359,764 +103,568	+40%	+$1.63M	0.01%	823
2025 Q2	$3.96M	Buy	256,196 +242,347	+1,750%	+$4.32M	0.01%	1008
2025 Q1	$269K	Buy	+13,849	New	+$291K	﹤0.01%	2531

Other funds holding CLBT

TWCM

True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return

Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return

Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

NTCM

Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Wealth Enhancement Advisory Services's CLBT Position: Q2 2026 in Review

Wealth Enhancement Advisory Services increased its Cellebrite (CLBT) stake by 4.1% in Q2 2026, buying an estimated $211K and bringing the position to 407,132 shares worth $6.49M. The position accounts for 0.01% of the portfolio, ranked #863.

Wealth Enhancement Advisory Services first reported a position in CLBT in Q1 2025 and has held it in 6 quarters since. The position peaked at $7.15M in Q4 2025. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

Wealth Enhancement Advisory Services held 407,132 shares of Cellebrite worth $6.49M as of Q2 2026.
Wealth Enhancement Advisory Services bought 15,957 Cellebrite shares in Q2 2026, an estimated $211K.
Cellebrite made up 0.01% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #863 holding.
Wealth Enhancement Advisory Services first reported a position in Cellebrite in Q1 2025 and has held it in 6 quarters since.
Wealth Enhancement Advisory Services's Cellebrite position peaked at $7.15M in Q4 2025.
201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.